433 related articles for article (PubMed ID: 34671158)
1. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.
Zhang SM; Cai WL; Liu X; Thakral D; Luo J; Chan LH; McGeary MK; Song E; Blenman KRM; Micevic G; Jessel S; Zhang Y; Yin M; Booth CJ; Jilaveanu LB; Damsky W; Sznol M; Kluger HM; Iwasaki A; Bosenberg MW; Yan Q
Nature; 2021 Oct; 598(7882):682-687. PubMed ID: 34671158
[TBL] [Abstract][Full Text] [Related]
2. SETDB1-Mediated Silencing of Retroelements.
Fukuda K; Shinkai Y
Viruses; 2020 May; 12(6):. PubMed ID: 32486217
[TBL] [Abstract][Full Text] [Related]
3. Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer.
Guan T; Zhang Y; Li S; Zhang W; Song Y; Li Y; He Y; Chen Y
Eur J Med Chem; 2024 Jun; 272():116494. PubMed ID: 38749268
[TBL] [Abstract][Full Text] [Related]
4. Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27.
Wang D; Han S; Peng R; Jiao C; Wang X; Yang X; Yang R; Li X
J Exp Clin Cancer Res; 2016 Feb; 35():37. PubMed ID: 26911146
[TBL] [Abstract][Full Text] [Related]
5. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance.
Xu W; Zhou B; Zhao X; Zhu L; Xu J; Jiang Z; Chen D; Wei Q; Han M; Feng L; Wang S; Wang X; Zhou J; Jin H
Int J Biol Sci; 2018; 14(9):1122-1132. PubMed ID: 29989047
[TBL] [Abstract][Full Text] [Related]
6. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z
Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382
[TBL] [Abstract][Full Text] [Related]
7. KDM5B protein expressed in viable and fertile ΔARID mice exhibit no demethylase activity.
Jamshidi S; Catchpole S; Chen J; So CWE; Burchell J; Rahman KM; Taylor-Papadimitriou J
Int J Oncol; 2021 Nov; 59(5):. PubMed ID: 34713299
[TBL] [Abstract][Full Text] [Related]
8. Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor.
Kristensen LH; Nielsen AL; Helgstrand C; Lees M; Cloos P; Kastrup JS; Helin K; Olsen L; Gajhede M
FEBS J; 2012 Jun; 279(11):1905-14. PubMed ID: 22420752
[TBL] [Abstract][Full Text] [Related]
9. Blockade of Immune-Checkpoint B7-H4 and Lysine Demethylase 5B in Esophageal Squamous Cell Carcinoma Confers Protective Immunity against
Yuan X; Liu Y; Li G; Lan Z; Ma M; Li H; Kong J; Sun J; Hou G; Hou X; Ma Y; Ren F; Zhou F; Gao S
Cancer Immunol Res; 2019 Sep; 7(9):1440-1456. PubMed ID: 31350278
[TBL] [Abstract][Full Text] [Related]
10. Histone lysine demethylase KDM5B maintains chronic myeloid leukemia via multiple epigenetic actions.
Xue S; Lam YM; He Z; Zheng Y; Li L; Zhang Y; Li C; Mbadhi MN; Zheng L; Cheng Z; Liu Y; Wang X; Chan LC; Ng RK; Zhang J
Exp Hematol; 2020 Feb; 82():53-65. PubMed ID: 32007477
[TBL] [Abstract][Full Text] [Related]
11. KDOAM-25 Overcomes Resistance to MEK Inhibitors by Targeting KDM5B in Uveal Melanoma.
Zhang H; Liu X; Chen Y; Xu R; He S
Biomed Res Int; 2022; 2022():1556485. PubMed ID: 36212716
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer.
Yeh IJ; Esakov E; Lathia JD; Miyagi M; Reizes O; Montano MM
Sci Rep; 2019 Nov; 9(1):17663. PubMed ID: 31776402
[TBL] [Abstract][Full Text] [Related]
13. H3K4 demethylase KDM5B regulates cancer cell identity and epigenetic plasticity.
He R; Xhabija B; Gopi LK; Kurup JT; Xu Z; Liu Z; Kidder BL
Oncogene; 2022 May; 41(21):2958-2972. PubMed ID: 35440714
[TBL] [Abstract][Full Text] [Related]
14. Histone demethylase KDM5B is a key regulator of genome stability.
Li X; Liu L; Yang S; Song N; Zhou X; Gao J; Yu N; Shan L; Wang Q; Liang J; Xuan C; Wang Y; Shang Y; Shi L
Proc Natl Acad Sci U S A; 2014 May; 111(19):7096-101. PubMed ID: 24778210
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase lysine demethylase 5B in development and cancer.
Han M; Xu W; Cheng P; Jin H; Wang X
Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the histone demethylase Kdm5b promotes neurogenesis and derepresses Reln (reelin) in neural stem cells from the adult subventricular zone of mice.
Zhou Q; Obana EA; Radomski KL; Sukumar G; Wynder C; Dalgard CL; Doughty ML
Mol Biol Cell; 2016 Feb; 27(4):627-39. PubMed ID: 26739753
[TBL] [Abstract][Full Text] [Related]
17. KDM5B is a master regulator of the H3K4-methylome in stem cells, development and cancer.
Xhabija B; Kidder BL
Semin Cancer Biol; 2019 Aug; 57():79-85. PubMed ID: 30448242
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity.
Griffin GK; Wu J; Iracheta-Vellve A; Patti JC; Hsu J; Davis T; Dele-Oni D; Du PP; Halawi AG; Ishizuka JJ; Kim SY; Klaeger S; Knudsen NH; Miller BC; Nguyen TH; Olander KE; Papanastasiou M; Rachimi S; Robitschek EJ; Schneider EM; Yeary MD; Zimmer MD; Jaffe JD; Carr SA; Doench JG; Haining WN; Yates KB; Manguso RT; Bernstein BE
Nature; 2021 Jul; 595(7866):309-314. PubMed ID: 33953401
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity.
Hu H; Khodadadi-Jamayran A; Dolgalev I; Cho H; Badri S; Chiriboga LA; Zeck B; Lopez De Rodas Gregorio M; Dowling CM; Labbe K; Deng J; Chen T; Zhang H; Zappile P; Chen Z; Ueberheide B; Karatza A; Han H; Ranieri M; Tang S; Jour G; Osman I; Sucker A; Schadendorf D; Tsirigos A; Schalper KA; Velcheti V; Huang HY; Jin Y; Ji H; Poirier JT; Li F; Wong KK
Cancer Immunol Res; 2021 Nov; 9(11):1298-1315. PubMed ID: 34462284
[TBL] [Abstract][Full Text] [Related]
20. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
